Vivia Biotech
Vivia Biotech is a Madrid-based, privately held precision-medicine company founded in 2007 that delivers solutions to patients, clinicians, and pharmaceutical companies, operating with a lean team of 11–50 employees under founder-led scientific and commercial leadership.
- Company typePrivate
- Founded2007
- HeadquartersMadrid, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Vivia Biotech does
Vivia Biotech is a privately held precision-medicine company founded in 2007 and headquartered in Madrid, Spain. Per its stated description, it provides precision medicine solutions to three distinct user groups: patients, clinicians, and pharmaceutical companies, positioning it at the intersection of clinical diagnostics and biopharma services. The company operates with a small team of 11–50 employees under a dual Ballesteros leadership — Andrés Ballesteros as CEO and Joan Ballesteros as Chairman & CSO — with Joaquin Martinez serving as medical director.
The underlying technology, specific product/service catalog, and pricing structure are not documented in the available input data. The only accessible web source returned a verification/loading page rather than substantive product information, which limits technical due diligence. Based on the company name, founding date, and stated focus on precision medicine, the business most plausibly sits in the drug-response profiling, hematology-oncology screening, or biomarker discovery space that several small European biotechs occupied in the late 2000s and early 2010s, but this cannot be confirmed from the data on hand.
On the commercial side, only one funding event is recorded: a $9.4 million round in April 2012 led by Clave Capital and Clave Mayor, two Spanish institutional investors. No subsequent raises, partnerships, customer wins, or product launches are visible in the input. Revenue, contract structure, and customer mix are not disclosed. As a result, the company's current scale, revenue trajectory, and competitive positioning cannot be triangulated beyond the fact that it remains operational and privately held more than 15 years after founding.
Vivia Biotech firmographics
Firmographics- Name
- Vivia Biotech
- Website
- https://viviabiotech.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vivia Biotech is a Madrid-based, privately held precision-medicine company founded in 2007 that delivers solutions to patients, clinicians, and pharmaceutical companies, operating with a lean team of 11–50 employees under founder-led scientific and commercial leadership.
- Ownership category
- akta.pro rank
Vivia Biotech industry classification
Industry- Product category
- Precision Medicine and Drug Discovery Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Translational Medicine & Biomarkers (HLAIALAF)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)
Keywords
Where Vivia Biotech is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Markets served
Vivia Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Vivia Biotech product offering
Product offeringCore offering
Vivia Biotech provides precision medicine solutions that combine proprietary ex vivo drug sensitivity testing with hematology expertise to identify effective therapies for patients and to support pharmaceutical companies in drug discovery and development. The company serves three customer groups: individual patients, clinicians making treatment decisions, and pharmaceutical firms seeking translational drug response data.
Differentiator
Problem solved
Functional benefit
Products and services
- Ex Vivo Hematological Drug Sensitivity Testing Proprietary functional precision medicine testing service that evaluates patient-derived hematological samples against candidate therapies to identify effective drugs for individual patients; serves clinicians treating hematological malignancies and patients seeking personalized therapy selection.
- Pharmaceutical Drug Discovery and Translational Research Services Collaborative research and translational services that apply Vivia Biotech's ex vivo drug sensitivity testing platform to support pharmaceutical companies in hematology and oncology drug discovery, candidate prioritization, and translational drug response profiling.
Companies that use Vivia Biotech
Customer profileIdeal customer profiles2 records
Vivia Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Vivia Biotech partnerships and signals
Strategic signalRecent moves3 records
Vivia Biotech competitors and assessment
Company assessmentDirect peers
- Champions Oncology: Champions Oncology develops patient-derived xenograft (PDX) and ex vivo tumor models used by pharma companies for drug screening and translational research, directly analogous to Vivia Biotech's patient-derived functional testing platform serving pharma R&D.
- Certis Oncology Solutions: Certis provides patient-derived tumor models and functional drug screening services for oncology drug development, mirroring Vivia Biotech's positioning as a precision medicine service provider serving pharmaceutical sponsors with patient-derived testing.
Peers
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key highlights4 records
Customer concentration
Vivia Biotech social profiles
Digital presenceVivia Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vivia Biotech leadership team
Management profileNumber of profiles
Profiles3 records
Vivia Biotech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vivia Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vivia Biotech
What does Vivia Biotech do?
Vivia Biotech provides precision medicine solutions that combine proprietary ex vivo drug sensitivity testing with hematology expertise to identify effective therapies for patients and to support pharmaceutical companies in drug discovery and development. The company serves three customer groups: individual patients, clinicians making treatment decisions, and pharmaceutical firms seeking translational drug response data.
When was Vivia Biotech founded?
Vivia Biotech was founded in 2007. It employs 11 to 50 people.
Where is Vivia Biotech based?
Vivia Biotech is headquartered in Madrid, Spain, in the Europe region.
Who are Vivia Biotech's main competitors?
Direct peers on record are Champions Oncology and Certis Oncology Solutions. Eurofins Scientific is listed as a peer.
Does Vivia Biotech have an API?
No public API is recorded for Vivia Biotech.
What industry is Vivia Biotech in?
Vivia Biotech's product category is Precision Medicine and Drug Discovery Services. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.